OptimizeRx
OPRX
121 hedge funds and large institutions have $567M invested in OptimizeRx in 2021 Q1 according to their latest regulatory filings, with 43 funds opening new positions, 34 increasing their positions, 36 reducing their positions, and 8 closing their positions.
438% more first-time investments, than exits
New positions opened: 43 | Existing positions closed: 8
326% more call options, than puts
Call options by funds: $44.1M | Put options by funds: $10.3M
83% more capital invested
Capital invested by funds: $310M → $567M (+$257M)
41% more funds holding
Funds holding: 86 → 121 (+35)
2.96% more ownership
Funds ownership: 66% → 68.96% (+3%)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
6% less repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 36
Top Buyers
| 1 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$37.3M |
| 2 |
PCM
Peregrine Capital Management
Minneapolis,
Minnesota
|
+$11.4M |
| 3 |
Two Sigma Investments
New York
|
+$9.42M |
| 4 |
Two Sigma Advisers
New York
|
+$7.32M |
| 5 |
MS
Maven Securities
St Helier,
Jersey
|
+$7.24M |
Top Sellers
| 1 |
AIC
AWM Investment Company
New York
|
-$9.65M |
| 2 |
GIPM
G2 Investment Partners Management
New York
|
-$9.38M |
| 3 |
SAM
Silvercrest Asset Management
New York
|
-$7.33M |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$5.34M |
| 5 |
EI
EAM Investors
Solana Beach,
California
|
-$4.43M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
126
Qube Research & Technologies (QRT)
London,
United Kingdom
| – | -$215K | -6,895 | Closed |
|
127
Simplex Trading
Chicago,
Illinois
| – | -$95.9K | -1,988 | Closed |
|
|
AF
128
Advisornet Financial
Minnetonka,
Minnesota
| – | -$3K | -100 | Closed |
|
OPRX Hedge Fund Activity: Q1 2021 in Review
121 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in OptimizeRx (OPRX) for Q1 2021, worth a combined $567M — up 83% from $310M a quarter earlier.
Buyers outnumbered sellers: 43 funds opened new OPRX positions and 8 closed out — a net gain of 35 holders — while 34 added to existing stakes and 36 trimmed.
The largest buyer was Artisan Partners, opening a new position worth an estimated $37.3M. The largest seller was AWM Investment Company, cutting an estimated $9.65M.
- 121 institutional investors held OptimizeRx (OPRX) as of Q1 2021, up from 86 in Q4 2020.
- Funds reported $567M of OptimizeRx stock for Q1 2021, up 83% quarter-over-quarter.
- 43 funds opened new OptimizeRx positions in Q1 2021 and 8 closed out, a net change of +35 holders.
- The largest OptimizeRx buyer in Q1 2021 was Artisan Partners, an estimated $37.3M added.
- The largest OptimizeRx seller in Q1 2021 was AWM Investment Company, an estimated $9.65M sold.
Based on aggregated 13F filings for Q1 2021.